NO180804C - Fettsyreblandinger - Google Patents

Fettsyreblandinger

Info

Publication number
NO180804C
NO180804C NO922183A NO922183A NO180804C NO 180804 C NO180804 C NO 180804C NO 922183 A NO922183 A NO 922183A NO 922183 A NO922183 A NO 922183A NO 180804 C NO180804 C NO 180804C
Authority
NO
Norway
Prior art keywords
fatty acid
acid mixtures
glycerol
dlmg
linoleoyl
Prior art date
Application number
NO922183A
Other languages
English (en)
Other versions
NO922183D0 (no
NO180804B (no
NO922183L (no
Inventor
David Frederick Horrobin
Yung-Sheng Huang
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of NO922183D0 publication Critical patent/NO922183D0/no
Publication of NO922183L publication Critical patent/NO922183L/no
Publication of NO180804B publication Critical patent/NO180804B/no
Publication of NO180804C publication Critical patent/NO180804C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)
  • Logic Circuits (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
NO922183A 1991-06-03 1992-06-02 Fettsyreblandinger NO180804C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111900A GB9111900D0 (en) 1991-06-03 1991-06-03 Fatty acid compositions

Publications (4)

Publication Number Publication Date
NO922183D0 NO922183D0 (no) 1992-06-02
NO922183L NO922183L (no) 1992-12-04
NO180804B NO180804B (no) 1997-03-24
NO180804C true NO180804C (no) 1997-07-02

Family

ID=10695999

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922183A NO180804C (no) 1991-06-03 1992-06-02 Fettsyreblandinger

Country Status (20)

Country Link
US (4) US5328691A (no)
EP (1) EP0520624B1 (no)
JP (1) JP2704922B2 (no)
KR (2) KR100274727B1 (no)
AT (1) ATE136214T1 (no)
AU (1) AU652827B2 (no)
CA (1) CA2069600C (no)
DE (1) DE69209571T2 (no)
DK (1) DK0520624T3 (no)
ES (1) ES2085567T3 (no)
FI (1) FI103867B (no)
GB (1) GB9111900D0 (no)
GR (1) GR3019840T3 (no)
HK (1) HK4597A (no)
IE (1) IE75224B1 (no)
NO (1) NO180804C (no)
NZ (1) NZ242898A (no)
SG (1) SG49739A1 (no)
TW (1) TW288975B (no)
ZA (1) ZA923913B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
FR2706304B1 (fr) * 1993-06-15 1995-09-01 Carita Sa Utilisation des huiles de Chaulmoogra dans le domaine cosmétique et pharmaceutique, notamment en dermatologie, pour harmoniser la pigmentation de la peau.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
EP0707850A1 (en) * 1994-09-21 1996-04-24 Scotia Holdings Plc Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
AU733734B2 (en) * 1996-03-28 2001-05-24 Gist-Brocades B.V. Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
CN1217029A (zh) * 1996-03-28 1999-05-19 吉斯特-布罗卡迪斯股份有限公司 从用巴氏法灭菌的生物量中制备含有微生物多不饱和脂肪酸的油的方法
ATE426430T1 (de) * 1997-07-16 2009-04-15 Metacure N V Einrichtung zur steuerung eines glatten muskels
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
ATE369868T1 (de) 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
CN104138606A (zh) 2002-06-19 2014-11-12 帝斯曼知识产权资产管理有限公司 用于微生物细胞和微生物油的巴氏消毒方法
WO2004012753A1 (en) * 2002-07-31 2004-02-12 Helfried Hans Rudolf Crede Pharmaceutical composition containing black cumin oil, flax oil and borago oil
US7255972B2 (en) 2002-10-23 2007-08-14 Az Electronic Materials Usa Corp. Chemically amplified positive photosensitive resin composition
MXPA05008216A (es) * 2003-01-31 2005-10-05 Procter & Gamble Medios para mejorar la apariencia del tejido queratinoso mamifero.
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
JP2006061021A (ja) * 2004-08-24 2006-03-09 Suntory Ltd 1種類の高度不飽和脂肪酸残基3個から成るトリグリセライドの製造方法、およびその利用
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2010042037A (ja) * 2009-11-26 2010-02-25 Suntory Holdings Ltd 1種類の高度不飽和脂肪酸残基3個から成るトリグリセライドの製造方法、およびその利用
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2015071766A1 (en) 2013-11-15 2015-05-21 Dignity Sciences Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
JP2017516823A (ja) 2014-06-04 2017-06-22 ディグニティ サイエンシス リミテッド Dglaを含む薬学的組成物及びその使用
CN107666904B (zh) * 2015-03-26 2022-02-01 提贝托·布鲁泽塞 多不饱和脂肪酸的纯化组合物、其制备方法及其用途
JP2018524274A (ja) 2015-05-13 2018-08-30 ディーエス バイオファーマ リミテッド 15−オキソ−epaまたは15−オキソ−dglaを含む組成物、ならびにその作製及び使用方法
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
DE2942021A1 (de) * 1979-10-17 1981-04-30 Bristol Myers Co Dermatologisches mittel
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
US5011855A (en) * 1982-04-16 1991-04-30 Nestec S.A. Cosmetic and dermatological compositions containing γ-linolenic acid
DE3368377D1 (en) * 1982-04-16 1987-01-29 Nestle Sa Lipid composition for oral, enteral or parenteral feeding
IE54795B1 (en) * 1982-04-29 1990-02-14 Efamol Ltd Pharmaceutical composition
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2569347B1 (fr) * 1984-08-22 1987-10-23 Mollet Marc Composition lipidique favorisant la pousse des phaneres et produits cosmetiques en renfermant
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
JPS6284041A (ja) * 1985-10-08 1987-04-17 Nitto Electric Ind Co Ltd γ−リノレン酸含有包接物
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
JPS6451496A (en) * 1987-08-21 1989-02-27 Nippon Oils & Fats Co Ltd Method of refining oil containing gamma-linolenic acid
FR2623692B1 (fr) * 1987-11-30 1991-05-03 Vernin Jean Gilles Nouvelle huile dietetique
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
IE63225B1 (en) * 1988-09-13 1995-04-05 Efamol Holdings Use of fatty acids in the treatment of myalgic encephalomyelitis
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy

Also Published As

Publication number Publication date
AU1727892A (en) 1992-12-10
FI103867B1 (fi) 1999-10-15
EP0520624A1 (en) 1992-12-30
ZA923913B (en) 1993-02-24
ATE136214T1 (de) 1996-04-15
DK0520624T3 (da) 1996-05-06
HK4597A (en) 1997-01-17
FI922542A0 (fi) 1992-06-02
IE921663A1 (en) 1992-12-16
US5328691A (en) 1994-07-12
NO922183D0 (no) 1992-06-02
CA2069600A1 (en) 1992-12-04
DE69209571T2 (de) 1996-09-05
US5552150A (en) 1996-09-03
US5614208A (en) 1997-03-25
DE69209571D1 (de) 1996-05-09
KR100277424B1 (ko) 2000-12-15
FI103867B (fi) 1999-10-15
NO180804B (no) 1997-03-24
EP0520624B1 (en) 1996-04-03
GR3019840T3 (en) 1996-08-31
FI922542A (fi) 1992-12-04
JP2704922B2 (ja) 1998-01-26
GB9111900D0 (en) 1991-07-24
NO922183L (no) 1992-12-04
JPH05201924A (ja) 1993-08-10
NZ242898A (en) 1994-12-22
SG49739A1 (en) 1998-06-15
KR100274727B1 (ko) 2000-12-15
KR930000664A (ko) 1993-01-15
ES2085567T3 (es) 1996-06-01
CA2069600C (en) 2004-05-04
US5620701A (en) 1997-04-15
TW288975B (no) 1996-10-21
AU652827B2 (en) 1994-09-08
IE75224B1 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
NO180804C (no) Fettsyreblandinger
ES2056220T3 (es) Composicion cosmetica.
ES2094788T3 (es) Composicion nutritiva.
ES2033434T3 (es) Composicion cosmetica.
DE69333581D1 (de) Modifizierte fettmischungen
DE60040096D1 (de) Zusammensetzung enthaltend ozonisierte öle und/oder andere natürliche und/oder synthetische ozonizierte produkte und ihre verwendung in pharmazeutischen, kosmetischen, diätetischen oder nahrungsergänzenden zusammensetzungen in human- und veterinärgebieten
DK0631772T3 (da) Retinoidholdig sammensætning
GR3002216T3 (en) Cosmetic product, particularly a skin hydratation product
DE69024321D1 (de) Oxydationsschutz eines Nahrungsmittels, eines kosmetischen Produktes oder eines pharmazeutischen Produktes
DE68901222D1 (de) Fettloesliches vitamin k enthaltende wasserloesung.
ATE56867T1 (de) Etofenamat-zubereitung.
DE3761467D1 (de) Haarversorgungsmittel.
RO95866B1 (ro) Crema de fata cu biostimulatori pentru ten uscat

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2003